Kronos Bio, Inc. - Common Stock (KRON)

Historical Holders from Q4 2020 to Q2 2025

Type / Class
Equity / Common Stock
Symbol
KRON
Price from insider filings
$0.5700
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Kronos Bio, Inc. - Common Stock (KRON) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q2 0 $0 -$15,790,182 0
2025 Q1 19,132,784 $15,790,464 -$625,093 $0.8250 47
2024 Q4 19,649,673 $18,665,523 -$792,903 $0.9500 56
2024 Q3 19,704,103 $19,700,585 -$2,248,644 $0.9999 52
2024 Q2 20,645,660 $25,556,191 -$1,590,484 $1.24 55
2024 Q1 21,700,397 $28,231,891 -$6,453,976 $1.30 57
2023 Q4 26,745,874 $33,427,928 -$4,595,965 $1.25 58
2023 Q3 30,266,227 $39,328,312 -$2,264,963 $1.30 63
2023 Q2 31,591,332 $54,317,965 -$1,182,464 $1.72 80
2023 Q1 32,396,272 $47,327,252 -$3,356,353 $1.46 86
2022 Q4 34,494,303 $55,877,865 -$2,972,560 $1.62 94
2022 Q3 36,074,689 $120,851,708 -$3,060,166 $3.35 90
2022 Q2 36,910,104 $134,378,804 -$21,147,007 $3.64 90
2022 Q1 38,994,222 $282,032,437 -$21,840,911 $7.23 91
2021 Q4 41,046,470 $557,830,415 +$1,058,701 $13.59 80
2021 Q3 35,955,919 $753,633,856 -$25,676,168 $20.96 80
2021 Q2 39,757,863 $952,008,187 +$87,935,702 $23.95 76
2021 Q1 33,255,601 $969,057,123 +$55,820,261 $29.27 69
2020 Q4 31,348,530 $928,520,047 +$915,228,048 $29.87 69